Related Experiment Video

Updated: Aug 19, 2026

Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

Cot deaths in Australia, 1985

J L Emery

    The Medical Journal of Australia
    |April 28, 1986
    PubMed

    Insights

    Cot deaths in Australia show varying infection roles by region, similar subclinical lesions to the UK, and a truly elevated rate in Tasmania. Coordinated research is needed to understand postperinatal deaths.

    Area of Science:

    • Pathology
    • Epidemiology
    • Public Health

    Background:

    • Cot death (Sudden Infant Death Syndrome) pathology varies geographically.
    • Understanding regional differences in infant mortality is crucial for targeted interventions.

    Purpose of the Study:

    • To survey the pathology of cot deaths across Australia.
    • To compare Australian findings with international data, particularly the United Kingdom.
    • To identify needs for coordinated research in postperinatal mortality.

    Main Methods:

    • A survey of cot death pathology was conducted in Australia.
    • Data on infection and subclinical lesions were analyzed.
    • Cot death rates in different regions (Melbourne, Western Australia, Tasmania) were compared.

    Main Results:

    • Infection plays a more significant role in Melbourne cot deaths than in Western Australia, but less than in the UK.
    • Subclinical lesions in Australian cot deaths resemble those found in the UK.
    • Tasmania exhibits a genuinely high cot death rate, not attributable to diagnostic variations.
    • Several areas report high rates of "possibly preventable" postperinatal deaths.

    Conclusions:

    • Cot death pathology and contributing factors exhibit regional variations within Australia.
    • There is a need for centralized coordination of research on the background factors and pathology of postperinatal deaths in Australia.
    • Collaboration among researchers could enhance understanding and prevention strategies for cot deaths.

    More Related Videos

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model07:20

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

    Published on: February 10, 2023

    Related Concept Videos

    Anticholinesterase Agents: Poisoning and Treatment01:26

    Anticholinesterase Agents: Poisoning and Treatment

    Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
    Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
    Toxicity Testing in Animals01:23

    Toxicity Testing in Animals

    Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
    Pharmaceutical Poisoning: Treatment Strategies01:26

    Pharmaceutical Poisoning: Treatment Strategies

    Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
    Coronary Artery Disease III: Clinical Manifestations01:30

    Coronary Artery Disease III: Clinical Manifestations

    Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
    Introduction Cardiac Emergencies01:30

    Introduction Cardiac Emergencies

    Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
    Inhalation Anthrax01:25

    Inhalation Anthrax

    Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...